1. Home
  2. STRO vs GMM Comparison

STRO vs GMM Comparison

Compare STRO & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • GMM
  • Stock Information
  • Founded
  • STRO 2003
  • GMM 2017
  • Country
  • STRO United States
  • GMM China
  • Employees
  • STRO N/A
  • GMM N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • GMM
  • Sector
  • STRO Health Care
  • GMM
  • Exchange
  • STRO Nasdaq
  • GMM Nasdaq
  • Market Cap
  • STRO 77.7M
  • GMM 70.8M
  • IPO Year
  • STRO 2018
  • GMM 2023
  • Fundamental
  • Price
  • STRO $0.90
  • GMM $2.78
  • Analyst Decision
  • STRO Hold
  • GMM
  • Analyst Count
  • STRO 7
  • GMM 0
  • Target Price
  • STRO $5.47
  • GMM N/A
  • AVG Volume (30 Days)
  • STRO 1.2M
  • GMM 22.9K
  • Earning Date
  • STRO 05-08-2025
  • GMM 06-10-2025
  • Dividend Yield
  • STRO N/A
  • GMM N/A
  • EPS Growth
  • STRO N/A
  • GMM 62.17
  • EPS
  • STRO N/A
  • GMM 6.37
  • Revenue
  • STRO $66,434,000.00
  • GMM $41,360,953.00
  • Revenue This Year
  • STRO N/A
  • GMM N/A
  • Revenue Next Year
  • STRO N/A
  • GMM N/A
  • P/E Ratio
  • STRO N/A
  • GMM $0.44
  • Revenue Growth
  • STRO N/A
  • GMM 53.82
  • 52 Week Low
  • STRO $0.52
  • GMM $1.69
  • 52 Week High
  • STRO $5.17
  • GMM $15.60
  • Technical
  • Relative Strength Index (RSI)
  • STRO 50.82
  • GMM 50.45
  • Support Level
  • STRO $0.86
  • GMM $2.64
  • Resistance Level
  • STRO $0.99
  • GMM $2.99
  • Average True Range (ATR)
  • STRO 0.09
  • GMM 0.31
  • MACD
  • STRO 0.00
  • GMM 0.02
  • Stochastic Oscillator
  • STRO 68.44
  • GMM 49.41

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: